Sphera Funds Management »

Cabaletta Bio shares owned by Sphera Funds Management

Quarter-by-quarter ownership of Cabaletta Bio (CABA) shares owned by Sphera Funds Management from 13F filings

Historical chart of Sphera Funds Management investment in Cabaletta Bio

Tip: Access up to 7 years of quarterly data

All positions including Cabaletta Bio held by Sphera Funds Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cabaletta Bio by Sphera Funds Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $4.1M 1.3M 3.11

More positions owned by Sphera Funds Management

Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Biogen Idec (BIIB)
Mineralys Therapeutics (MLYS)
Tower Semiconductor Shs New (TSEM)
Cytokinetics Com New (CYTK)
Spdr Series Trust St Str Sp Biot Put Option (XBI)
Syndax Pharmaceuticals (SNDX)
Ultragenyx Pharmaceutical (RARE)
BioMarin Pharmaceutical (BMRN)
Bridgebio Pharma (BBIO)
Cogent Biosciences (COGT)
NOVA MEASURING Instruments L (NVMI)
Insmed Com Par $.01 (INSM)
Maze Therapeatics (MAZE)
Astrazeneca Ord (AZN)

View all positions for Sphera Funds Management

Top funds holding Cabaletta Bio

Jennison Associates
Bain Capital Life Sciences Investors
BlackRock
Adage Capital Partners GP
Vanguard Capital Management
Cormorant Asset Management
Woodline Partners
Citadel Advisors
Norges Bank Investment Management
Opaleye Management
Geode Capital Management
Susquehanna International
Franklin Resources
Goldman Sachs Group
Millennium Management

View all funds holding Cabaletta Bio